Literature DB >> 33498621

The Alkaloid-Enriched Fraction of Pachysandra terminalis (Buxaceae) Shows Prominent Activity against Trypanosoma brucei rhodesiense.

Dagmar Flittner1, Marcel Kaiser2,3, Pascal Mäser2,3, Norberto P Lopes4, Thomas J Schmidt1.   

Abstract

In the course of our studies on antiprotozoal natural products and following our recent discovery that certain aminosteroids and aminocycloartanoid compounds from Holarrhena africana A. DC. (Apocynaceae) and Buxus sempervirens L. (Buxaceae), respectively, are strong and selective antitrypanosomal agents, we have extended these studies to another plant, related to the latter-namely, Pachysandra terminalis Sieb. and Zucc. (Buxaceae). This species is known to contain aminosteroids similar to those of Holarrhena and structurally related to the aminocycloartanoids of Buxus. The dicholoromethane extract obtained from aerial parts of P. terminalis and, in particular, its alkaloid fraction obtained by acid-base partitioning showed prominent activity against Trypanosoma brucei rhodesiense (Tbr). Activity-guided fractionation along with extended UHPLC-(+)ESI QTOF MS analyses coupled with partial least squares (PLS) regression modelling relating the analytical profiles of various fractions with their bioactivity against Tbr highlighted eighteen constituents likely responsible for the antitrypanosomal activity. Detailed analysis of their (+)ESI mass spectral fragmentation allowed identification of four known constituents of P. terminalis as well as structural characterization of ten further amino-/amidosteroids not previously reported from this plant.

Entities:  

Keywords:  Buxaceae; Pachysandra terminalis; Trypanosoma brucei; mass spectrometry; steroid alkaloid

Mesh:

Substances:

Year:  2021        PMID: 33498621      PMCID: PMC7865568          DOI: 10.3390/molecules26030591

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  18 in total

1.  Cytotoxic alkaloids of Pachysandra terminalis.

Authors:  S Funayama; T Noshita; K Shinoda; N Haga; S Nozoe; M Hayashi; K Komiyama
Journal:  Biol Pharm Bull       Date:  2000-02       Impact factor: 2.233

2.  New bioactive steroidal alkaloids from Buxus hyrcana.

Authors:  Zaheer Uddin Babar; Athar Ata; Mohammad Hadi Meshkatalsadat
Journal:  Steroids       Date:  2006-10-17       Impact factor: 2.668

3.  Alkaloids from Pachysandra terminalis inhibit breast cancer invasion and have potential for development as antimetastasis therapeutic agents.

Authors:  Hui-Yuan Zhai; Chuan Zhao; Ning Zhang; Mei-Na Jin; Sheng-An Tang; Nan Qin; De-Xin Kong; Hong-Quan Duan
Journal:  J Nat Prod       Date:  2012-07-17       Impact factor: 4.050

4.  Oral fexinidazole for human African trypanosomiasis.

Authors:  François Chappuis
Journal:  Lancet       Date:  2018-01-13       Impact factor: 79.321

5.  4-dehydroxyepisarcovagine A, a new steroidal alkaloid from Sarcococca pruniformis Lindl.

Authors:  J-C Wu; S-J Huo; J Du
Journal:  Nat Prod Res       Date:  2018-02-16       Impact factor: 2.861

6.  Structure-Activity Relationships of Cinnamate Ester Analogues as Potent Antiprotozoal Agents.

Authors:  Freddy A Bernal; Marcel Kaiser; Bernhard Wünsch; Thomas J Schmidt
Journal:  ChemMedChem       Date:  2019-11-12       Impact factor: 3.466

7.  Terminamines K-S, Antimetastatic Pregnane Alkaloids from the Whole Herb of Pachysandra terminalis.

Authors:  Xiang-Yu Li; Yang Yu; Miao Jia; Mei-Na Jin; Nan Qin; Chuan Zhao; Hong-Quan Duan
Journal:  Molecules       Date:  2016-09-26       Impact factor: 4.411

8.  Antiprotozoal activity of Buxus sempervirens and activity-guided isolation of O-tigloylcyclovirobuxeine-B as the main constituent active against Plasmodium falciparum.

Authors:  Julia B Althaus; Gerold Jerz; Peter Winterhalter; Marcel Kaiser; Reto Brun; Thomas J Schmidt
Journal:  Molecules       Date:  2014-05-15       Impact factor: 4.411

9.  Potent Antitrypanosomal Activities of 3-Aminosteroids against African Trypanosomes: Investigation of Cellular Effects and of Cross-Resistance with Existing Drugs.

Authors:  Charles O Nnadi; Godwin U Ebiloma; Jennifer A Black; Ngozi J Nwodo; Leandro Lemgruber; Thomas J Schmidt; Harry P de Koning
Journal:  Molecules       Date:  2019-01-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.